knowledge -WSS

knowledge

author：comprehensive 2025-08-07 16:19:05 - browse：5

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Pancreatic cancer is often deadly, but new discoveries are raising hope

WSS

Study: Black kids more likely to die after surgery than white kids

How to pay for weight loss drugs and save Medicare

Young boy dies in trial for Pfizer Duchenne gene therapy

First Opinion on colorectal cancer screening: letter and response

Scientific mystery highlights the blind spots in genomics databases

Mayo Clinic plans $5B tech

focus

knowledge

explore

As demand for Covid shots wanes, Moderna seeks its next success

BIO selects John Crowley as new CEO

Heart attack and stroke risk calculators need revising

Pancreatic cancer is often deadly, but new discoveries are raising hope

The high cost of giving birth even with insurance

What to do when lifesaving products contribute to climate change

Medical leaders decry Supreme Court decision on affirmative action

Organ aging and disease risk measured by new blood test

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Pancreatic cancer is often deadly, but new discoveries are raising hope

entertainment

The EPA's new lead rule: How one expert crunched the numbers

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Oral obesity drug from Viking Therapeutics hits key early target

BIO selects John Crowley as new CEO

Drug companies' payments and gifts affect physicians' prescribing

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

hotspot

Wikipedia

leisure time

entertainment